Effect of inhaled furosemide on lung clearance of technetium-99m-DTPA

J Nucl Med. 1995 Jan;36(1):73-7.

Abstract

The diuretic furosemide has been reported to have a protective effect on allergic asthmatic reactions. This study was performed to investigate the effect of aerosolized furosemide on the lung clearance of 99mTc-diethylene triamine pentaacetic acid (99mTc-DTPA).

Methods: Pulmonary clearance rates of 99mTc-DTPA were measured by a computerized gamma camera with and without the inhalation of aerosol furosemide in 6 nonsmoking normal volunteers (Group 1), 7 smokers without pulmonary disease (Group 2) and 11 patients with asthma (Group 3).

Results: None of the six normal volunteers showed significant effects of inhaled furosemide on the 99mTc-DTPA clearance rates. Three of seven smokers presented an accelerated 99mTc-DTPA clearance by inhaled furosemide and the other four showed no significant change of 99mTc-DTPA clearance by furosemide inhalation. However, in 10 of 11 patients with asthma, there was significant suppression of 99mTc-DTPA clearance by furosemide inhalation.

Conclusion: Asthmatics possess a furosemide-sensitive mechanism. Pulmonary aerosol scintigraphy with 99mTc-DTPA will be useful in predicting the effect of inhaled furosemide therapy.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Administration, Inhalation
  • Adolescent
  • Adult
  • Asthma / drug therapy
  • Asthma / metabolism*
  • Female
  • Furosemide / pharmacology*
  • Furosemide / therapeutic use
  • Humans
  • Lung / drug effects*
  • Lung / metabolism
  • Male
  • Smoking / metabolism
  • Technetium Tc 99m Pentetate / pharmacokinetics*

Substances

  • Furosemide
  • Technetium Tc 99m Pentetate